- Home
- ALGS vs GLV Comparison
ALGS vs GLV Comparison
Compare ALGS & GLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- GLV
- Stock Information
- Founded
- ALGS 2018
- GLV 2004
- Country
- ALGS United States
- GLV United States
- Employees
- ALGS N/A
- GLV N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- GLV Finance/Investors Services
- Sector
- ALGS Health Care
- GLV Finance
- Exchange
- ALGS Nasdaq
- GLV Nasdaq
- Market Cap
- ALGS 64.8M
- GLV 74.1M
- IPO Year
- ALGS 2020
- GLV N/A
- Fundamental
- Price
- ALGS $8.31
- GLV $6.06
- Analyst Decision
- ALGS Strong Buy
- GLV
- Analyst Count
- ALGS 2
- GLV 0
- Target Price
- ALGS $60.00
- GLV N/A
- AVG Volume (30 Days)
- ALGS 102.0K
- GLV 54.2K
- Earning Date
- ALGS 11-06-2025
- GLV 01-01-0001
- Dividend Yield
- ALGS N/A
- GLV 12.44%
- EPS Growth
- ALGS N/A
- GLV N/A
- EPS
- ALGS N/A
- GLV N/A
- Revenue
- ALGS $3,174,000.00
- GLV N/A
- Revenue This Year
- ALGS N/A
- GLV N/A
- Revenue Next Year
- ALGS N/A
- GLV N/A
- P/E Ratio
- ALGS N/A
- GLV N/A
- Revenue Growth
- ALGS N/A
- GLV N/A
- 52 Week Low
- ALGS $3.76
- GLV $4.70
- 52 Week High
- ALGS $46.80
- GLV $6.06
- Technical
- Relative Strength Index (RSI)
- ALGS 37.09
- GLV 65.12
- Support Level
- ALGS $8.52
- GLV $5.84
- Resistance Level
- ALGS $10.06
- GLV $6.09
- Average True Range (ATR)
- ALGS 0.74
- GLV 0.09
- MACD
- ALGS -0.17
- GLV 0.01
- Stochastic Oscillator
- ALGS 1.86
- GLV 90.62
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About GLV Clough Global Dividend and Income Fund of beneficial interest
Clough Global Dividend and Income Fund is a closed-ended investment management company. The fund's investment objective is to provide a high level of total return. It invests in equity and debt securities in both U.S. and non-U.S. markets of companies of any market capitalization.